2023 Q3 Form 10-Q Financial Statement

#000189928723000097 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $2.798M $1.632M $691.0K
YoY Change 242.89% 136.18% -36.2%
Cost Of Revenue $7.046M $4.664M $2.081M
YoY Change 208.49% 124.12% 11.4%
Gross Profit -$4.248M -$3.032M -$1.390M
YoY Change 189.37% 118.13% 77.07%
Gross Profit Margin -151.82% -185.78% -201.16%
Selling, General & Admin $4.068M $6.279M $2.320M
YoY Change 71.86% 170.65% 178.51%
% of Gross Profit
Research & Development $815.0K $772.0K $451.0K
YoY Change 67.01% 71.18% 47.87%
% of Gross Profit
Depreciation & Amortization $400.0K $500.0K $390.0K
YoY Change 3.63% 28.21% 25.4%
% of Gross Profit
Operating Expenses $4.883M $7.051M $2.771M
YoY Change 71.03% 154.46% 143.5%
Operating Profit -$9.131M -$10.08M -$1.672M
YoY Change 111.22% 503.14% 16448.7%
Interest Expense $640.0K $640.0K $7.000K
YoY Change 710.13% 9042.86% 250.0%
% of Operating Profit
Other Income/Expense, Net $639.0K $635.0K $4.553M
YoY Change 708.86% -86.05% -75979.23%
Pretax Income -$8.490M -$9.450M -$4.154M
YoY Change 100.05% 127.49% 250.84%
Income Tax
% Of Pretax Income
Net Earnings -$8.500M -$9.400M $2.881M
YoY Change 100.28% -426.28% -28619.14%
Net Earnings / Revenue -303.79% -575.98% 416.93%
Basic Earnings Per Share -$0.10 -$0.11 -$0.06
Diluted Earnings Per Share -$0.10 -$0.11 -$49.35K
COMMON SHARES
Basic Shares Outstanding 86.27M shares 84.97M shares 65.78M shares
Diluted Shares Outstanding 86.35M shares 85.22M shares 65.78M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.40M $65.01M $5.243M
YoY Change -27.65% 1139.94%
Cash & Equivalents $53.40M $65.00M $1.966M
Short-Term Investments
Other Short-Term Assets $5.630M $4.060M $1.697M
YoY Change 106.15% 139.25%
Inventory $487.0K $503.0K $329.0K
Prepaid Expenses $223.4K
Receivables $1.900M $1.100M $490.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $61.39M $70.70M $2.190M
YoY Change -21.11% 3128.65%
LONG-TERM ASSETS
Property, Plant & Equipment $16.67M $6.903M $6.559M
YoY Change 336.01% 5.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $957.0K $702.0K $3.478M
YoY Change 58.44% -79.82%
Total Long-Term Assets $25.22M $15.94M $230.4M
YoY Change 190.46% -93.08%
TOTAL ASSETS
Total Short-Term Assets $61.39M $70.70M $2.190M
Total Long-Term Assets $25.22M $15.94M $230.4M
Total Assets $86.62M $86.64M $232.6M
YoY Change 0.13% -62.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.578M $597.0K $29.67K
YoY Change 35.48% 1911.93%
Accrued Expenses $5.649M $7.141M $1.154M
YoY Change 158.77% 518.6%
Deferred Revenue $3.569M $3.198M
YoY Change 348.93%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.88M $12.01M $1.184M
YoY Change 126.12% 913.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.980M $7.940M $3.056M
YoY Change 59.95% 159.82%
Total Long-Term Liabilities $6.980M $7.940M $3.056M
YoY Change 59.95% 159.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.88M $12.01M $1.184M
Total Long-Term Liabilities $6.980M $7.940M $3.056M
Total Liabilities $20.86M $19.95M $20.74M
YoY Change 98.66% -3.84%
SHAREHOLDERS EQUITY
Retained Earnings -$119.9M -$111.4M -$18.35M
YoY Change 38.08% 507.19%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $65.76M $66.69M -$18.35M
YoY Change
Total Liabilities & Shareholders Equity $86.62M $86.64M $232.6M
YoY Change 0.13% -62.75%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$8.500M -$9.400M $2.881M
YoY Change 100.28% -426.28% -28619.14%
Depreciation, Depletion And Amortization $400.0K $500.0K $390.0K
YoY Change 3.63% 28.21% 25.4%
Cash From Operating Activities -$8.670M -$5.590M -$2.449M
YoY Change 222.07% 128.26% 82.08%
INVESTING ACTIVITIES
Capital Expenditures $8.930M $1.730M -$160.0K
YoY Change 1514.83% -1181.25% -19.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.930M -$1.730M -$160.0K
YoY Change 1514.83% 981.25% -19.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.990M 8.140M -431.0K
YoY Change -91.66% -1988.63% -127.23%
NET CHANGE
Cash From Operating Activities -8.670M -5.590M -2.449M
Cash From Investing Activities -8.930M -1.730M -160.0K
Cash From Financing Activities 5.990M 8.140M -431.0K
Net Change In Cash -11.61M 820.0K -3.040M
YoY Change -116.93% -126.97% -7700.0%
FREE CASH FLOW
Cash From Operating Activities -$8.670M -$5.590M -$2.449M
Capital Expenditures $8.930M $1.730M -$160.0K
Free Cash Flow -$17.60M -$7.320M -$2.289M
YoY Change 442.37% 219.79% 99.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
700000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2600000 usd
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13858000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2022Q1 ampx Adjustments To Additional Paid In Capital Capital Contributions From Parent
AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent
247000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
456000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2878000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11537000 usd
CY2022Q2 ampx Adjustments To Additional Paid In Capital Capital Contributions From Parent
AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent
258000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
890000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
8531000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18550000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7032000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1650000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1346000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
856000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
748000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
402000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1252000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
506000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
280000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
444000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
228000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-171000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1304000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1045000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-915000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-305000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-94000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3903000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
75000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
761000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-754000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-453000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-218000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12075000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5492000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2868000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2868000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10507000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
254000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
ampx Payment Of Transaction And Issuance Costs In Connection With Business Combination And Pipe Investment
PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment
0 usd
ampx Payment Of Transaction And Issuance Costs In Connection With Business Combination And Pipe Investment
PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment
740000 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
505000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10257000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-227000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4686000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5913000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11489000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65066000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5576000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65010000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5243000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
56000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
333000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65066000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5576000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9400000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18600000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111400000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65000000 usd
CY2023Q2 ampx Committed Equity Financing Remaining Balance
CommittedEquityFinancingRemainingBalance
189400000 usd
CY2023Q2 ampx Project Grant Value
ProjectGrantValue
50000000 usd
CY2022Q3 ampx Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
1.45590
ampx Number Of Executive Employees Of Parent Sharing Facilities Costs
NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts
2 executiveemployee
ampx Number Of Executive Employees Of Parent Sharing Facilities Costs
NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts
2 executiveemployee
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationCertain accounts in the prior period condensed consolidated statements of operations were reclassified to conform with the current period presentation. The reclassification had no impact to our net loss and cash flows in those periods.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div>Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
56000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
56000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskAccounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through June 30, 2023, we have not experienced any credit losses.
CY2022Q2 us-gaap Revenues
Revenues
691000 usd
us-gaap Revenues
Revenues
2311000 usd
us-gaap Revenues
Revenues
2801000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1100000 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
300000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4100000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3400000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2900000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1400000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10400000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7800000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11480000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7244000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4236000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
700000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
481000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1828000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1840000 usd
CY2023Q2 ampx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
712000 usd
CY2022Q4 ampx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
0 usd
CY2023Q2 ampx Accrued Purchases Of Inventory
AccruedPurchasesOfInventory
417000 usd
CY2022Q4 ampx Accrued Purchases Of Inventory
AccruedPurchasesOfInventory
0 usd
CY2023Q2 ampx Accrued Offering Costs Current
AccruedOfferingCostsCurrent
12000 usd
CY2022Q4 ampx Accrued Offering Costs Current
AccruedOfferingCostsCurrent
194000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
193000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
193000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7141000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2708000 usd
CY2023Q2 ampx Shares Authorized
SharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7000000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
47720736 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
924000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
890000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1650000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1346000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q2 ampx Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
0 lease
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5200000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
304000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
139000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
506000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
278000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
79000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
40000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
132000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
80000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
16000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
42000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
39000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
406000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
195000 usd
us-gaap Lease Cost
LeaseCost
680000 usd
us-gaap Lease Cost
LeaseCost
397000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
548000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1126000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1158000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1193000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1241000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1278000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4729000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11273000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3205000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8068000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9448000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9448000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4154000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4154000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18550000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18550000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7032000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7032000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85216827 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85216827 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65776550 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65776550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84932542 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84932542 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65775545 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65775545 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62023151 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14095402 shares

Files In Submission

Name View Source Status
0001899287-23-000097-index-headers.html Edgar Link pending
0001899287-23-000097-index.html Edgar Link pending
0001899287-23-000097.txt Edgar Link pending
0001899287-23-000097-xbrl.zip Edgar Link pending
ampx-20230630.htm Edgar Link pending
ampx-20230630.xsd Edgar Link pending
ampx-20230630xexhibit311.htm Edgar Link pending
ampx-20230630xexhibit312.htm Edgar Link pending
ampx-20230630xexhibit321.htm Edgar Link pending
ampx-20230630xexhibit322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
ampx-20230630_def.xml Edgar Link unprocessable
ampx-20230630_lab.xml Edgar Link unprocessable
ampx-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ampx-20230630_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ampx-20230630_cal.xml Edgar Link unprocessable